The global IVD market is valued at approximately $113 billion in 2026 and is projected to reach $157 billion by 2030 at a CAGR of 7.6%, driven by rising chronic disease prevalence, aging populations, expanding molecular diagnostics, and the accelerating shift to point-of-care testing. IVD tests now influence approximately 70% of all clinical decisions. Roche, Abbott, Danaher, Siemens Healthineers, bioMérieux, Sysmex, QuidelOrtho, Hologic, Bio-Rad, and DiaSorin collectively account for over 60% of global IVD revenues and are deploying AI, automation, and menu expansion to extend their competitive positions.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Global IVD Market Size and Forecast 2025-2030 by Segment, Technology, and Region
• High-Growth Segments — Molecular Diagnostics, Point-of-Care, Liquid Biopsy, and AI-Enabled Diagnostics
• Business Strategies of the World's 10 Leading IVD Suppliers
• Competitive Positioning, Market Share, and Portfolio Analysis
• Technology Investment Priorities — NGS, AI, Digital Pathology, and Automation
• Regional Dynamics — North America, Europe, Asia-Pacific, Latin America, and Middle East
• M&A Activity and Strategic Alliances 2023-2025
• Investment and Partnership Opportunities
• Strategic Recommendations for Market Entry and Expansion
Table of Contents
1. Executive Summary
2. Market Overview
3. High-Growth Opportunity Analysis
3.1 AI and Laboratory Automation
3.2 Point-of-Care Testing
3.3 Oncology and Liquid Biopsy
3.4 Emerging Markets Expansion
3.5 Immunoassay and Clinical Chemistry Consolidation
3.6 Hematology, Coagulation, and Urinalysis
3.7 Regulatory Transformation
4. Competitive Landscape Overview
5. Regional Market Analysis
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (38 countries)
5.3 Asia-Pacific (18 countries)
5.4 Latin America (22 countries)
5.5 Middle East (11 countries)
5.6 Africa and Rest of World
6. Company Profiles — The World’s Leading IVD Suppliers
6.1 Abbott Diagnostics
6.2 Bio-Rad Laboratories
6.3 bioMérieux
6.4 Danaher (Beckman Coulter, Cepheid, Radiometer)
6.5 DiaSorin
6.6 Hologic
6.7 QuidelOrtho
6.8 Roche Diagnostics
6.9 Siemens Healthineers
6.10 Sysmex
7. Strategic Conclusions and Recommendations
8. Appendix
List of Tables
Table 1. Global IVD Market Size and Growth 2020-2030 by Segment
Table 2. Market Segmentation by Technology 2025
Table 3. Market Segmentation by End-User 2025
Table 4. Key Demand Drivers and Impact Assessment 2025-2030
Table 5. AI and Laboratory Automation — Platform Comparison and Leading Suppliers 2025
Table 6. Point-of-Care Testing — Application Landscape and Leading Suppliers 2025
Table 7. Oncology and Liquid Biopsy — Application Landscape and Leading Suppliers 2025
Table 8. Immunoassay and Clinical Chemistry — Platform Competition 2025
Table 9. Hematology, Coagulation, and Urinalysis — Leading Suppliers 2025
Table 10. Recent M&A Transactions 2023-2025
Table 11. North America and Europe IVD Market Analysis 2025-2030
Table 12. Asia-Pacific IVD Market Analysis 2025-2030
Table 13. Latin America and Middle East IVD Market Analysis 2025-2030
Table 14. World’s Leading Suppliers Revenue Comparison 2023-2025
Table 15. World’s Leading Suppliers R&D Investment Comparison 2023-2025
Table 16. World’s Leading Suppliers Geographic Revenue Distribution 2025
Table 17. World’s Leading Suppliers M&A Activity Summary 2023-2025
Table 18. World’s Leading Suppliers Strategic Priorities 2025-2030
Companies Profiled
Abbott
bioMérieux
DiaSorin
Hologic
Quidel
Roche
Siemens
Siemens Healthineers
Sysmex
